{
    "2021-11-07": [
        [
            {
                "time": "2023-10-17",
                "original_text": "天风证券维持长春高新买入评级：业绩表现亮眼，持续保持生长激素行业龙头地位",
                "features": {
                    "keywords": [
                        "天风证券",
                        "长春高新",
                        "买入评级",
                        "业绩表现",
                        "生长激素",
                        "行业龙头"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-17",
                "original_text": "天风证券：给予长春高新买入评级",
                "features": {
                    "keywords": [
                        "天风证券",
                        "长春高新",
                        "买入评级"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}